BioSpace News Archive

Press Releases

Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights

March 30, 2026
·
11 min read
Press Releases

Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis

March 30, 2026
·
6 min read
Press Releases

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

March 30, 2026
·
7 min read
Press Releases

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma

March 30, 2026
·
6 min read
Press Releases

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 30, 2026
·
11 min read
Press Releases

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy

March 30, 2026
·
5 min read
Press Releases

Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026

March 30, 2026
·
7 min read
Press Releases

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study

March 30, 2026
·
10 min read
Press Releases

Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program

March 30, 2026
·
4 min read
Press Releases

Connect Biopharma Announces $20.2 Million Private Placement Financing

March 30, 2026
·
5 min read